Suspended

18-FDG PET Imagery and MRI Comparison in Cervical Cancer Lymph Node Metastasis Detection

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Data Collection

Who is being recruted

Urogenital Diseases+10

+ Genital Diseases

+ Uterine Cervical Diseases

Over 18 Years
+13 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Diagnostic Study

Phase 2
Interventional
Study Start: October 2003
See protocol details

Summary

Principal SponsorUniversity Hospital, Limoges
Study ContactDominique GENET, MD
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: October 1, 2003

Actual date on which the first participant was enrolled.

Cervical cancer treatment depends on factors like tumor size and lymph node involvement. Early-stage cervical cancers without lymph node involvement are typically treated with surgery, radiotherapy, or both. However, advanced stages often require radio-chemotherapy, either alone or before surgery. Current pre-treatment examinations include a clinical examination and a pelvic MRI to assess lymph nodes and tumor spread. This study aims to explore the potential benefits of using an 18-FDG PET scan alongside the MRI for better lymph node detection in cervical cancer patients, potentially improving treatment planning and outcomes. The study is a multicenter, multidisciplinary effort involving 380 patients over 3 years. Participants will undergo both an 18-FDG PET scan and an MRI before starting any treatment. The results of these scans will be compared to determine which method is more accurate in detecting pelvic and para-aortic lymph node metastasis. The findings will also be correlated with histology results from lymph node dissection. This comparison will help estimate the effectiveness of the 18-FDG PET scan in diagnosing cervical cancer spread.

Official TitleInterest of PET Imagery With 18-FDG in the Extension Assessment of the Cervical Cancer
Principal SponsorUniversity Hospital, Limoges
Study ContactDominique GENET, MD
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

42 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Diagnostic Study

Diagnostic studies focus on improving how we detect or confirm a disease. They test new tools or techniques that could provide faster or more accurate diagnoses.


Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Female

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Urogenital DiseasesGenital DiseasesUterine Cervical DiseasesUterine Cervical NeoplasmsFemale Urogenital Diseases and Pregnancy ComplicationsGenital Diseases, FemaleGenital Neoplasms, FemaleNeoplasmsNeoplasms by SiteUrogenital NeoplasmsUterine DiseasesUterine NeoplasmsFemale Urogenital Diseases

Criteria

5 inclusion criteria required to participate
Patient with cervical carcinoma: histological proof of epidermoid carcinoma or of adenocarcinoma

Stage I to IV (limited to pelvic) (FIGO Classification) (see appendix 3)

Age ≥ 18 years old

No contra-indication to surgery

Show More Criteria

8 exclusion criteria prevent from participating
Metastatic cervical cancer with extra-pelvic metastasis

Contra-indication to MRI: implantation of an electronic device, metallic or ferromagnetic foreign body

Serious co-existing affection with vital prognosis

Diabetes uncontrolled by a classical treatment: glycaemia > 1.4g/l

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 3 locations

Recruiting

Gynécologie Obstétrique

Limoges, FranceOpen Gynécologie Obstétrique in Google Maps
Recruiting

Médecine Nucléaire

Limoges, France
Recruiting

Oncologie Médicale

Limoges, France
Suspended3 Study Centers